Current pharmacologic treatment of brain metastasis in non-small cell lung cancer

Clin Exp Metastasis. 2024 Mar 11. doi: 10.1007/s10585-024-10276-4. Online ahead of print.ABSTRACTLung cancer is a type of cancer that can metastasize to the lungs, brain, bones, liver, adrenal glands, and other organs; however, the occurrence of brain metastases is the most common event. Symptoms of brain metastasis include motor dysfunction, mental dysfunction, seizures, headaches, nausea, and vomiting, and significantly reduce the quality of life of cancer patients. Brain metastases are a poor prognostic factor, and controlling them is extremely important for prolonging prognosis and improving the quality of life. Currently, local surgery and radiotherapy are recommended for their treatment. However, recently, cancer treatments using molecular-targeted drugs and immune checkpoint inhibitors have been introduced, which may also be effective against brain metastases. Therefore, it is necessary to determine whether local or systemic therapy is optimal for each case. In this review, we focus on recent findings regarding drug therapy in treating brain metastases from advanced non-small cell lung cancer.PMID:38466521 | DOI:10.1007/s10585-024-10276-4
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research